Welcome to our dedicated page for Dupont De Nemours SEC filings (Ticker: DD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The DuPont de Nemours, Inc. (NYSE: DD) SEC filings page provides access to the company’s official disclosures filed with the U.S. Securities and Exchange Commission. These documents include current reports on Form 8-K, annual and quarterly reports when available, and exhibits that describe material agreements, capital structure changes and significant portfolio transactions.
DuPont’s recent 8-K filings illustrate how its SEC documents can inform investors about major corporate events. In 2025, DuPont filed multiple 8-Ks detailing the separation of its electronics business into Qnity Electronics, Inc., including the Separation and Distribution Agreement, Tax Matters Agreement, Employee Matters Agreement, Intellectual Property Cross-License Agreement, Transition Services Agreements and a Legacy Liabilities Assignment Agreement. Another 8-K furnishes unaudited pro forma consolidated financial information reflecting DuPont’s post-separation structure.
Filings also describe the planned divestiture of DuPont’s aramids business, including Kevlar and Nomex, through a Transaction Agreement with entities affiliated with Arclin. Additional 8-Ks outline DuPont’s debt and capital markets activities, such as exchange offers for senior notes, supplemental indentures, issuance of new notes, special mandatory redemption provisions, consent solicitations and tender offers for portions of its long-dated notes. These documents provide detailed terms of DuPont’s obligations and capital structure adjustments.
Investors can review DuPont’s 8-K dated November 6, 2025 for quarterly financial results and segment information, including the IndustrialsCo and ElectronicsCo segments prior to the Qnity separation. Other filings report on board and executive changes, as well as the determination of percentages used to calculate Minimum EBITDA thresholds under legacy agreements following the Qnity spin-off.
On Stock Titan, DuPont filings are updated as they are released to EDGAR, and AI-powered summaries can help explain the key points in complex documents such as transaction agreements, supplemental indentures and pro forma financial statements. Users can use this page to locate DuPont’s 10-K and 10-Q reports when filed, as well as Form 8-K disclosures that highlight material events, enabling a deeper understanding of the company’s evolving portfolio, governance and financial commitments.
DuPont de Nemours, Inc. is soliciting proxies for its 2026 Annual Meeting of Stockholders to be held online on May 21, 2026, with a record date of March 30, 2026. The Board recommends voting for all 11 director nominees and for approval of executive compensation, ratification of the independent auditor, and an amendment to effect a reverse stock split and reduce authorized shares.
The proxy highlights corporate governance practices, executive compensation design (including 2025 STIP and LTI decisions), committee responsibilities, and succession planning. The filing discloses 409,854,272 shares outstanding as of March 13, 2026, beneficial ownership schedules, non-employee director pay elements, and proposed Certificate of Amendment language for the reverse split.
DuPont de Nemours, Inc. plans a reverse stock split of its common stock, subject to stockholder approval, at a ratio between 1-for-2 and 1-for-4, with the exact ratio to be set later by the Board of Directors.
If implemented, the company will proportionally reduce authorized common shares. DuPont states the reverse split will not affect stockholder voting or other rights, business operations, or outstanding debt. The proposal will be voted on at the Annual Meeting of Stockholders on May 21, 2026, with a record date of March 30, 2026. The Board may delay or abandon the reverse split even if it is approved.
DuPont de Nemours, Inc. reports that it expects to close the previously announced sale of its aramids business, which includes the Kevlar and Nomex product lines, to Arclin on April 1, 2026. All regulatory conditions required to complete the sale were satisfied as of March 10, 2026.
The company notes that statements about the timing and completion of the transaction are forward-looking and subject to various risks, including potential closing conditions, separation impacts and the future performance of the Arclin entity in which DuPont expects to hold a minority interest.
DuPont de Nemours, Inc. director Alexander M. Cutler reported an automatic acquisition of common stock. On 2026-02-27, he received 999.2006 shares at $50.04 per share as a grant or similar award, including dividend reinvestment, increasing his direct holdings to 76,609.0025 shares.
DuPont de Nemours, Inc. director Frederick M. Lowery reported an acquisition of common stock through an award. On this Form 4, he received 774.3804 shares of DuPont common stock at a reported price of $50.04 per share, increasing his directly held stake to 35,290.2764 shares. The filing notes that this total includes shares acquired through dividend reinvestment.
DuPont de Nemours, Inc. director Donald G. Macpherson reported an acquisition of common stock through a grant or award. He received 216.4934 shares of DuPont common stock at a reference price of $50.04 per share, bringing his directly owned stake to 1,162.4934 shares.
DuPont de Nemours, Inc. director Donald G. Macpherson reported the acquisition of 946 shares of common stock through a grant or award. The shares were recorded at a price of $0.00 per share, indicating they were awarded rather than purchased on the open market. Following this transaction, he directly holds 946 common shares of DuPont de Nemours. The filing notes that the transaction was reported late due to an inadvertent administrative error.
DuPont de Nemours SVP & General Counsel Erik T. Hoover reported two stock transactions. He received a grant of 11,903 shares of common stock at no cost, then had 2,583 shares withheld at $50.36 per share to cover taxes on lapsed RSUs and related dividend equivalents.
DuPont de Nemours, Inc. executive Jeroen Bloemhard reported two equity transactions in company stock. On February 20, 2026, he acquired 9,919 shares of common stock as a grant or award at $0.00 per share, increasing his direct holdings.
On February 21, 2026, 1,028 shares were disposed of at $50.36 per share to cover tax withholding on lapsed RSUs and related dividend equivalent units, according to the footnote. After these transactions, he directly owned 24,770.0519 shares of DuPont common stock.
DuPont de Nemours, Inc. SVP & CFO Antonella B. Franzen reported two stock transactions. On February 20, she acquired 19,838 shares of common stock as a grant or award at $0 per share, increasing her direct holdings. On February 21, 1,631 shares were disposed of at $50.36 per share to satisfy tax withholding on lapsed RSUs and related dividend equivalents, leaving her with 70,360.5346 shares directly owned.